Having this genetic context available during a provider conversation can support a more personalized discussion about energy management, appropriate monitoring, and whether semaglutide or an alternative compounded GLP-1 or GLP-1/GIP combination (like PlexusDx Tirzepatide or GLP-Squared) might better suit your individual physiology
For some people, other treatments, including oral weight loss drugs, are a better option
This may be due to changes in metabolism, blood sugar fluctuations, or increased hunger leading to inconsistent energy levels throughout the day
We want to make it easy to find what you're looking for
Recientemente, la Sociedad Argentina de Ciruga de la Obesidad (SACO) emiti una declaracin firmada por su presidente, Jorge Harraca, en la que expresa la preocupacin ante mensajes que circulan en redes sociales de profesionales de la salud que, segn su perspectiva, presentan nuevas alternativas teraputicas para la obesidad como soluciones mgicas